nach oben

Clinical Research in Cardiology

Erschienen in:

01.03.2012 | Original Paper

Smoking restrictions and hospitalization for acute coronary events in Germany

verfasst von: James D. Sargent, Eugene Demidenko, David J. Malenka, Zhongze Li, Helmut Gohlke, Reiner Hanewinkel

Erschienen in: Clinical Research in Cardiology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims

To study the effects of smoking restrictions in Germany on coronary syndromes and their associated costs.

Methods and results

All German states implemented laws partially restricting smoking in the public and hospitality sectors between August 2007 and July 2008. We conducted a before-and-after study to examine trends for the hospitalization rate for angina pectoris and acute myocardial infarction (AMI) for an insurance cohort of 3,700,384 individuals 30 years and older. Outcome measures were hospitalization rates for coronary syndromes, and hospitalization costs. Mean age of the cohort was 56 years, and two-thirds were female. Some 2.2 and 1.1% persons were hospitalized for angina pectoris and AMI, respectively, during the study period from January 2004 through December 2008. Law implementation was associated with a 13.3% (95% confidence interval 8.2, 18.4) decline in angina pectoris and an 8.6% (5.0, 12.2) decline in AMI after 1 year. Hospitalization costs also decreased significantly for the two conditions—9.6% (2.5, 16.6) for angina pectoris and 20.1% (16.0, 24.2) for AMI at 1 year following law implementation. Assuming the law caused the observed declines, it prevented 1,880 hospitalizations and saved 7.7 million Euros in costs for this cohort during the year following law implementation.

Conclusions

Partial smoking restrictions in Germany were followed by reductions in hospitalization for angina pectoris and AMI, declines that continued through 1 year following these laws and resulted in substantial cost savings. Strengthening the laws could further reduce morbidity and costs from acute coronary syndromes in Germany.

Peto R, Lopez AD, Boreham J, Thun M, Heath C (1994) Mortality from smoking in developed countries 1950–2000. Indirect estimates from national vital statistics. Oxford University Press, Oxford

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364(9438):937–952PubMedCrossRef

Gohlke H, Yusuf S (2007) Quantitating loss of life by smoking a single cigarette. Clin Res Cardiol 96(7):522–523PubMedCrossRef

Sherif MA, Nienaber CA, Toelg R, Abdel-Wahab M, Geist V, Schneider S et al (2011) Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol 100(5):413–423PubMedCrossRef

US Department of Health and Human Services (2006) The health consequences of involuntary exposure to tobacco: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health

Glantz SA, Parmley WW (1995) Passive smoking and heart disease. Mechanisms and risk. JAMA 273(13):1047–1053PubMedCrossRef

Law MR, Morris JK, Wald NJ (1997) Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 315(7114):973–980PubMedCrossRef

Sun YP, Zhu BQ, Sievers RE, Glantz SA, Parmley WW (1994) Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation 89(5):2260–2265PubMed

Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW (1993) Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 21(1):225–232PubMedCrossRef

10.

Hutchison SJ, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM et al (1999) Effects of l-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke. Hypertension 34(1):44–50PubMed

11.

Kallio K, Jokinen E, Raitakari OT, Hamalainen M, Siltala M, Volanen I et al (2007) Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation 115(25):3205–3212PubMedCrossRef

12.

Leone A, Balbarini A (2008) Exposure to passive smoking: a test to predict endothelial dysfunction and atherosclerotic lesions. Angiology 59(2):220–223PubMedCrossRef

13.

Elwood PC, Renaud S, Sharp DS, Beswick AD, O’Brien JR, Yarnell JW (1991) Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 83(1):38–44PubMed

14.

Schmidt KG, Rasmussen JW (1984) Acute platelet activation induced by smoking. In vivo and ex vivo studies in humans. Thromb Haemost 51(2):279–282PubMed

15.

Pope CA III, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE et al (2009) Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure–response relationship. Circulation 120(11):941–948PubMedCrossRef

16.

Centers for Disease Control and Prevention (CDC) (2009) Reduced hospitalizations for acute myocardial infarction after implementation of a smoke-free ordinance–City of Pueblo, Colorado, 2002–2006. MMWR Morb Mortal Wkly Rep 57(51):1373–1377

17.

Barnoya J, Glantz SA (2006) Cardiovascular effects of second-hand smoke help explain the benefits of smoke-free legislation on heart disease burden. J Cardiovasc Nurs 21(6):457–462PubMed

18.

Barone-Adesi F, Vizzini L, Merletti F, Richiardi L (2006) Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J 27(20):2468–2472PubMedCrossRef

19.

Bartecchi C, Alsever RN, Nevin-Woods C, Thomas WM, Estacio RO, Bartelson BB et al (2006) Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation 114(14):1490–1496PubMedCrossRef

20.

Cesaroni G, Forastiere F, Agabiti N, Valente P, Zuccaro P, Perucci CA (2008) Effect of the Italian smoking ban on population rates of acute coronary events. Circulation 117(9):1183–1188PubMedCrossRef

21.

Jones SC, Travers MJ, Hahn EJ, Robertson H, Lee K, Higbee C et al (2006) Secondhand smoke and indoor public spaces in Paducah, Kentucky. J Ky Med Assoc 104(7):281–288PubMed

22.

Juster HR, Loomis BR, Hinman TM, Farrelly MC, Hyland A, Bauer UE et al (2007) Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health 97(11):2035–2039PubMedCrossRef

23.

Khuder SA, Milz S, Jordan T, Price J, Silvestri K, Butler P (2007) The impact of a smoking ban on hospital admissions for coronary heart disease. Prev Med 45(1):3–8PubMedCrossRef

24.

Lemstra M, Neudorf C, Opondo J (2008) Implications of a public smoking ban. Can J Public Health 99(1):62–65PubMed

25.

Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C et al (2008) Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 359(5):482–491PubMedCrossRef

26.

Sargent RP, Shepard RM, Glantz SA (2004) Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ 328(7446):977–980PubMedCrossRef

27.

Seo DC, Torabi MR (2007) Reduced admissions for acute myocardial infarction associated with a public smoking ban: matched controlled study. J Drug Educ 37(3):217–226PubMedCrossRef

28.

Bonetti PO, Trachsel LD, Kuhn MU, Schulzki T, Erne P, Radovanovic D et al (2011) Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubunden, Switzerland: two year follow-up. Swiss Med Wkly 141:w13206PubMed

29.

Herman PM, Walsh ME (2011) Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona’s comprehensive statewide smoking ban. Am J Public Health 101(3):491–496PubMedCrossRef

30.

Naiman A, Glazier RH, Moineddin R (2010) Association of anti-smoking legislation with rates of hospital admission for cardiovascular and respiratory conditions. CMAJ 182(8):761–767PubMedCrossRef

31.

Sims M, Maxwell R, Bauld L, Gilmore A (2010) Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ 340:c2161PubMedCrossRef

32.

Villalbi JR, Sanchez E, Benet J, Cabezas C, Castillo A, Guarga A et al (2011) The extension of smoke-free areas and acute myocardial infarction mortality: before and after study. BMJ Open 1(1):000067

33.

Lightwood JM, Glantz SA (2009) Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation 120(14):1373–1379PubMedCrossRef

34.

Meyers DG, Neuberger JS, He J (2009) Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. J Am Coll Cardiol 54(14):1249–1255PubMedCrossRef

35.

Andersohn F, Schlattmann P, Roll S, Muller-Riemenschneider F, Binting S, Willich SN (2010) Regional variation of mortality from ischemic heart disease in Germany from 1998 to 2007. Clin Res Cardiol 99(8):511–518PubMedCrossRef

36.

Müller S, Kraus L, Piontek D, Pabst A (2011) Changes in exposure to secondhand smoke and smoking behavior. Sucht 56(5):3–373

37.

Bickel PJ (2001) Mathematical statistics, 2nd edn. Prentice-Hall, Upper Saddle River, NJ

38.

Fichtenberg CM, Glantz SA (2002) Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ 325(7357):188PubMedCrossRef

39.

Lampert M, List SM (2010) Tabak-Zahlen und Fakten zum Konsum. In: Deutsche Hauptstelle für Suchtfragen (ed) Jahrbuch Sucht 2010. Neuland, Geesthacht, pp 48–68

40.

Schuler J, Maier B, Behrens S, Thimme W (2006) Present treatment of acute myocardial infarction in patients over 75 years—data from the Berlin Myocardial Infarction Registry (BHIR). Clin Res Cardiol 95(7):360–367PubMedCrossRef

41.

Tebbe U, Messer C, Stammwitz E, The GS, Dietl J, Bischoff KO et al (2007) Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI). Dtsch Med Wochenschr 132(30):1559–1566PubMedCrossRef

42.

The Joint European Society of Cardiology/American College of Cardiology Committee (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21(18):1502–1513

43.

Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36(3):959–969PubMedCrossRef

44.

Gu YL, Voors AA, Zijlstra F, Hillege HL, Struck J, Masson S et al (2011) Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clin Res Cardiol 100(12):1069–1076

45.

Kurz K, Giannitsis E, Becker M, Hess G, Zdunek D, Katus HA (2011) Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol 100(3):209–215PubMedCrossRef

46.

Meiser F (2008) Effect of the modified definition of the myocardial infarct using troponin for diagnosis, therapy, and process of NSTEMI in clinical daily routine in Germany [Einfluss der geänderten Definition des Myokardinfarktes unter Berücksichtigung der Troponine auf Diagnose, Therapie und Verlauf des NSTEMI im klinischen Alltag in Deutschland]. Doctoral thesis, University of Heidelberg, Heidelberg

47.

IOM (Institute of Medicine) (2010) Secondhand smoke exposure and cardiovascular effects: making sense of the evidence. The National Academy Press, Washington, DC

Titel: Smoking restrictions and hospitalization for acute coronary events in Germany
verfasst von: James D. Sargent
Eugene Demidenko
David J. Malenka
Zhongze Li
Helmut Gohlke
Reiner Hanewinkel
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: Clinical Research in Cardiology / Ausgabe 3/2012
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-011-0385-1

Neu im Fachgebiet Kardiologie

23.04.2024 | Ablationstherapie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Smoking restrictions and hospitalization for acute coronary events in Germany

Abstract

Aims

Methods and results

Conclusions

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Aims

Methods and results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Time-dependency, predictors and clinical impact of infarct transmurality assessed by magnetic resonance imaging in patients with ST-elevation myocardial infarction reperfused by primary coronary percutaneous intervention

Early remodeling processes as predictors of diastolic function 5 years after reperfused acute myocardial infarction and intracoronary progenitor cell application

First clinical evaluation of a novel capacitive ECG system in patients with acute myocardial infarction

Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study

Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone

Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie